1/1828
Looks like no tags are added yet.
why are biologics given by injection or infusion?
stomach & intestines are build to breakdown proteins; stomach acid can denature a protein & digestive enzymes (proteases) cut it into small fragments, destroying its activity before it can be absorbed
biologics are very large, 100-1000x heavier than small-molc so cross intestinal lining poorly even when they survive digestion
injecting drugs avoids GIT altogether
main route for monoclonal Ab
IV
bc whole dose enters circulation, IV administration can deliver ________
large doses & volumes
disadvantage of IV
Most IV biologics are diluted into an IV bag and infused over a period of time, so the patient must come to a clinic or infusion center, and a trained healthcare professional prepares and gives the dose
advantages of SC biologic administration
take much less time than an IV infusion
don’t require skilled HCP
pt can give at home
many Ab stay in body for weeks so they can be given infreq
convenience!!!
disadvantages of SC biologic administration
only a small volume (2mL) can be inj comfortably under the skin so drug must be packed into very conc soln
higher conc protein soln have higher viscosity → more likely to aggregate
drug is absorbed slowly from tissue into blood
some of drug is broken down along the way so only part of the dose reaches circulation
peak levels take 2 days to develop
Before a biologic is approved, the manufacturer must show regulators how the product behaves under ___________
realistic conditions
stability studies for biologics
test the product at its intended storage temperature and under stress, including after reconstitution and dilution
photostability testing for biologics
exposes the product to light, and shipping studies simulate the vibration, drops, and temperature changes of real transport
results of stability & photostability testing of biologics
results of this testing become the storage conditions, shelf life, and preparation instructions on the product label.
3 types of stress biologics are sensitive to in storage and handling
temp
mechanical stress
light
most biologic products travel thru _______
cold chain
cold chain
a continuous series of refrigerated storage and transport steps designed to keep the product within the labeled temp range
temp excursion
any time the product falls outside its labeled range, either too warm or too cold.
Excursions in either direction can harm the product.
effect of warm excursion on biologic
speeds up unfolding & aggregation
mechanical stress on biologics
agitation (shaking, vibration, mixing)
shock (sudden jolts such as dropping a package)
what happens when a protein soln is shaken?
protein molecules collect at the boundary between the liquid and the air bubbles, where they can unfold and stick together.
what happens when a protein soln undergoes a sudden drop, even from a low height?
can create tiny vapor bubbles in the liquid that then collapse, a process called cavitation, which can trigger particle formation.
ex. pneumatic tube
is sunlight or indoor lighting more damaging to biologics?
sunlight
effect of light on biologics
can act on the protein directly, or indirectly through other ingredients in the formulation that absorb light and generate reactive species. The result can include oxidation, aggregation, loss of potency, and sometimes visible discoloration.
how do manufacturers address light damage in biologics?
protect products with amber glass containers and cardboard cartons, but that protection is lost once the product is taken out of its packaging
what kind of damage do temp, mechanical stress, and light cause to biologics?
cause the protein to unfold, fragment, or clump together (aggregate), and particles can form.
why do damaged biologic products work less well?
less active drug is present
Aggregates can also make the immune system recognize a damaged drug as foreign, leading to __________ that can reduce the drug’s effect or cause adverse reactions.
anti-drug antibodies
Because particles are a recognized quality concern, the United States Pharmacopeia (USP) sets limits on the number of _____________ allowed in therapeutic protein injections.
subvisible particles
which storage form of biologics is most vulnerable to stress?
liquid
how are liquid biologic products stored?
refrigerated within labeled range
protected from light in their carton
handled gently
formulation excipients such as surfactants & buffers are added to protect the protein
lyophilization
removes the water from a product, leaving a dry powder or “cake.” Without water, the protein is much more stable and microbes are less able to grow, so lyophilized products can be stored for long periods.
Sugars such as sucrose, trehalose, or mannitol are often added to protect the protein during drying and storage
disadvantage of lyophilized prod
must be reconstituted before given
adds prep step
prod becomes a fragile liquid again once it is dissolved, so it must be done exactly as the label describes
ex of frozen biologics
gene therapies
cell therapies
mRNA prod delivered in lipid nanoparticles
exposing a frozen prod to room temp during transfer can cause __________
thermal shock
uncontrolled freezing and thawing can damage _________________
viral particles or cells
main handling risks for frozen biologic storage forms
Breaks in the cold chain, thermal shock, freeze–thaw damage
main handling risks for lyophilized (freeze-dried powder) biologic storage forms
Becomes a fragile liquid once dissolved
main handling risks for liquid biologic storage
Heat, freezing, shaking, dropping, light
product label for biologics
includes detailed instructions for reconstitution, dilution, & storage after preparation
based on manufacturer’s testing
each opening of a multidose biologic container is a chance for _____________
microbial contamination
excipient for multidose biologics
antimicrobial preservatives
another name for the prepared dose (biologic)
dosing soln
the dosing soln can be more _____________ than the product in its original container
fragile
Diluting a biologic into an IV bag also dilutes the ____________ in the formulation
protective excipients
proteins tend to stick to (adsorb onto) surfaces such as …
plastic IV bags, tubing, filters, and the silicone oil used to lubricate syringes.
effect of adsorption
can lower the amount of drug the patient receives (underdosing), and adsorbed protein can unfold and seed further aggregation and particle formation
pt friendly devices for SC biologics
prefilled syringes
autoinjectors
on-body injectors that stick to the skin and deliver the dose automatically
why must biologic products stay in their original cartons?
to protect them from light
where in fridge should biologics be stored?
away from door
away from walls and other extremes
what should happen before a biologic dose is prepared or disp?
product should be inspected for damage or visible changes, such as particles or discoloration.
When doses are transported, including within the hospital, an appropriate _____________ helps protect them from drops, vibration, and temperature changes
secondary or insulated container
are excipients in biologics truly inactive?
no- commonly contain surfactants, sugars, and in multidose prod, preservatives
may cause injection-site rxns and allergic rxns
target of biologics
usually in plasma or on cell surface
monoclonal antibodies (mAbs) are often ________ specific
species
may not bind animal version of target
before using an animal model, check whether the animal…
o Expresses a version (ortholog) of the human target
o Has a target that binds the mAb with high affinity
o Has the target in similar tissues as humans
workarounds for finding the right species for mAbs
make a mouse version of the mAb or use transgenic animals that express the human target.
human and humanized proteins are __________ in animals
immunogenic
Anti-drug antibodies (ADAs) in animals lower exposure and can _________ toxicity.
underestimate
MABEL
Minimal anticipated biological effect level, based on expected target occupancy
the problem with using traditional NOAEL (1/10-1/100) in biologics
an animal that shows no harm may not respond like a human does
how is a safe first dose tested for biologics?
sentinel dosing— dose one subject & watch for a set time before anyone else
bioavailability of SC early clinical testing
50-70%, breakdown in tissue & lymph
peak plasma level after an SC biologics dose
3-7d (slow absorption)
half-life for SC biologics
11-30d
infrequent dosing
most mAbs trigger some ______ resp, which can…
ADA / alter PK, reduce efficacy, or cause side effects
resp are stronger on re-exposure, so __________ is assessed early in clinical trials
immunogenicity
2 licensing pathways for biologics
reference product
biosimilar
reference prod licensing pathway
“Stand-alone” BLA. Proves safety and effectiveness on its own: analytical, animal, clinical pharmacology, and clinical trials for each indication.
biosimilar licensing pathway for biologics
Abbreviated pathway. Proves the product is biosimilar to the reference product, so it does not repeat the reference product’s full clinical program
biosimilar
• A biologic that is highly similar to an FDA-approved reference product and has no clinically meaningful differences in safety, purity, and potency.
• Same route, dosage form, strength, and potential benefits and side effects as the reference product
are biosimilars generics?
no
4 parts of proving biosimilarity
analytical foundation = structural & functional comparison across multiple lots
clinical/pharm PK/PD = similar exposure & similar resp when a PD biomarker exists
immune resp ADAs = similar type and amt of immune resp
clinical study if needed = used only to resolve residual uncertainty
2 types of comparative analytical assays
physicochemical (structural)
biological (functional)
comparative analytical assessment focus
on quality attributes that affect clinical performance: molecular structure, bioactivity, and purity.
Example: post-translational modifications such as glycosylation
do excipients & process-related impurities have to match ref product?
no— checked for prod quality
are analytical or clinical studies more sensitive at detecting diff?
analytical
naming of biosimilars
share the reference product’s core name plus a unique 4-letter suffix with no meaning
purpose of biosimilar naming
pharmacovigilance (linking adverse events to the right product) and knowing which product was dispensed.
Use the suffix when prescribing, dispensing, record keeping, and reporting to MedWatch.
purple book
shows whether a biologic is a reference product, biosimilar, or interchangeable biosimilar.
interchangeable biosimilar
A biosimilar that a pharmacist may substitute for the reference product without the prescriber, subject to state law
extra standard for interchangeable biosimilars
expected to give the same clinical result in any given patient, and switching back and forth adds no more risk than staying on the reference product.
why is biosimilar competition limited?
cost to develop = $75-250 million (generic is 1-5million)
price drop ~30%
exclusivity = 12 years after reference product licensure before a biosimilar can be approved
price negotiation 11 yrs (7 for small molc)
adoption of biosimilars to pt
FDA approval
formulary inclusion and payor coverage which vary by insurer and plan
awareness & acceptance by pt and proiders
what kind of pt can biosimilars be used in?
treatment naive and treatment experienced
Biologics follow the same stages as small molecules, but ___________ and __________ change how they are tested
species specificity / immunogenicity
First-in-human doses for biologics use ________ and _________ because animal data can miss human effects
MABEL / sentinel dosing
foundation for totality of biosimilar evidence
analytical studies
Interchangeable biosimilars can be substituted at the pharmacy (subject to state law) but are not ________ than other biosimilars.
better
production of biologics (in a living cell)
The gene coding for the protein is inserted into a host cell, and the resulting cell line is frozen down as a cell bank so that every future batch starts from the same genetic point.
A vial of that bank is thawed, grown up through progressively larger vessels, and transferred into the production bioreactor, where the cells are fed nutrient medium under controlled temperature, pH and dissolved oxygen while they secrete the protein into the liquid around them.
The culture is then harvested, and cells and debris are removed by filtration or centrifugation, leaving a dilute solution of the product mixed with thousands of other proteins.
After the culture is harvested, the product is purified. The product is captured by binding it to a chromatography column that is selective for it while unwanted proteins wash straight through.
For antibodies, Protein A affinity chromatography is used, which binds the Fc region of the antibody. The bound product is then eluted with a low-pH buffer, and that acidic eluate is deliberately held at low pH for a set time, because those conditions inactivate any viruses that might have come from the cells or the raw materials.
Polishing chromatography removes residual impurities, aggregates and variants, and a virus filter adds a second, physical layer of virus safety.
Finally, the protein is concentrated, its buffer is exchanged for the formulation buffer, excipients are added, and the solution is sterile-filtered and filled
almost every step of biologic formation involves ________
stress
pumps & filters shear the soln
capture exposes the protein to acid
conc crowds the molc together
a protein that survives the bioreactor can still be damaged on its way to the vial
steps in biologic production chain
cell banking
cell culture
harvest & clarification
capture chromatography
virus inactivation
polishing & virus filtration
concentration & buffer exchange
formulation, filtration, & fill
cell banking (step 1)
A cell line carrying the gene is expanded and frozen in aliquot
Fixes the genetic starting point for every batch
cell culture (step 2)
Cells are fed in a bioreactor and secrete the protein
Sets glycosylation and other modifications; agitation and aeration stress the protein
harvest & clarification (step 3)
Cells and debris are separated from the fluid
Shear from pumps, centrifuges and filters
capture chromatography (step 4)
The product is bound, washed and then eluted at low pH
Acid exposure can begin to unfold the protein
virus inactivation (step 5)
The low-pH eluate is held for a set time
further acid stress
polishing and virus filtration (step 6)
Residual impurities, variants, aggregates and viruses are removed
Yield is lost, aggregates must already be low enough to filter
concentration & buffer exchange (step 7)
The process buffer is replaced by the formulation buffer
Crowding raises the risk of aggregation and high viscosity
formulation, filtration, and fill (step 8)
Excipients are added; the solution is sterile-filtered and filled
Air-liquid interfaces, pumping and container surfaces
Bacteria, usually Escherichia coli, grow quickly and cheaply and are a good fit for _________ proteins.
smaller, simpler
Mammalian cells, most often Chinese hamster ovary (CHO) cells, grow more slowly and cost far more to run, but they are used for ___________ and most other __________therapeutic proteins.
antibodies / complex
why are mammalian cells used for human proteins such as antibodies?
Human proteins such as antibodies carry chains of sugars attached to specific sites on the protein, a modification called glycosylation, and bacteria do not have the cellular machinery to attach human-type sugar chains
post-translational modification
change the cell makes to the protein after the chain has been assembled
most important = glycosylation
changes aren’t written in the gene but added by the cell’s own enzymes